User profiles for Christopher S. Coffey
Christopher S. CoffeyProfessor of Biostatistics, University of Iowa Verified email at uiowa.edu Cited by 19681 |
[PDF][PDF] AHA/ASA Guideline
Purpose—The aim of this guideline is to provide a focused update of the current recommendations
for the endovascular treatment of acute ischemic stroke. Where there is overlap, the …
for the endovascular treatment of acute ischemic stroke. Where there is overlap, the …
Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management …
…, RP Frantz, AJ Foreman, CS Coffey… - Circulation, 2010 - Am Heart Assoc
Background— Factors that determine survival in pulmonary arterial hypertension (PAH) drive
clinical management. A quantitative survival prediction tool has not been established for …
clinical management. A quantitative survival prediction tool has not been established for …
2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke …
Purpose— The aim of this guideline is to provide a focused update of the current recommendations
for the endovascular treatment of acute ischemic stroke. When there is overlap, the …
for the endovascular treatment of acute ischemic stroke. When there is overlap, the …
β-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction
Contextβ-Blocker therapy remains substantially underused in cardiac patients despite its
proven mortality benefits. Reluctance to prescribe these agents may derive from concerns …
proven mortality benefits. Reluctance to prescribe these agents may derive from concerns …
Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial
…, D Zygun, CS Coffey, P Drever, S Fourwinds… - The Lancet …, 2011 - thelancet.com
Background The inconsistent effect of hypothermia treatment on severe brain injury in
previous trials might be because hypothermia was induced too late after injury. We aimed to …
previous trials might be because hypothermia was induced too late after injury. We aimed to …
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
…, R Kurth, C Caspell-Garcia, CS Coffey… - The Lancet …, 2023 - thelancet.com
Background Emerging evidence shows that α-synuclein seed amplification assays (SAAs)
have the potential to differentiate people with Parkinson's disease from healthy controls. We …
have the potential to differentiate people with Parkinson's disease from healthy controls. We …
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease
…, CS Coffey, T Waligórska, P Taylor, S Pan… - JAMA …, 2013 - jamanetwork.com
Importance We observed a significant correlation between cerebrospinal fluid (CSF) levels
of tau proteins and α-synuclein, but not β-amyloid 1-42 (Aβ1-42), and lower concentration of …
of tau proteins and α-synuclein, but not β-amyloid 1-42 (Aβ1-42), and lower concentration of …
The Parkinson's progression markers initiative (PPMI)–establishing a PD biomarker cohort
…, A Siderowf, S Lasch, CS Coffey… - Annals of clinical …, 2018 - Wiley Online Library
… Christopher S. Coffey served as a consultant receiving consulting fees from The Michael J.
Fox Foundation for Parkinson's Research; Received research funding from NINDS, NHLBI, …
Fox Foundation for Parkinson's Research; Received research funding from NINDS, NHLBI, …
[HTML][HTML] Trial of amitriptyline, topiramate, and placebo for pediatric migraine
Background Which medication, if any, to use to prevent the headache of pediatric migraine
has not been established. Methods We conducted a randomized, double-blind, placebo-…
has not been established. Methods We conducted a randomized, double-blind, placebo-…
Natural history of infantile‐onset spinal muscular atrophy
Objective Infantile‐onset spinal muscular atrophy (SMA) is the most common genetic cause
of infant mortality, typically resulting in death preceding age 2. Clinical trials in this …
of infant mortality, typically resulting in death preceding age 2. Clinical trials in this …